Bleichroeder LP Fate Therapeutics Inc Transaction History

Bleichroeder LP

  • $296 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$59.27 - $95.73 $5.93 Million - $9.57 Million
-100,000 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$30.41 - $40.5 $607,348 - $808,866
19,972 Added 24.96%
100,000 $4 Million
Q2 2020

Aug 12, 2020
BUY
$20.21 - $35.23 $1.62 Million - $2.82 Million
80,028 New
80,028 $2.75 Million

Others Institutions Holding FATE

# of Institutions
177
Shares Held
113M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $130M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email